Approved July 2022 Novavax: New COVID Vaccine May be Available Soon

My daughter and son in law did not have any more information from Novavax, however the following announcement from Novavax may shed some light. At the end of the article it did mention a booster dose of Novavax can help people who are vaccinated by other vaccines. So read the whole thing. My daughter feels that since I was vaccinated early, I really should have a booster as soon as it's available. In Isreal, people over 60 are getting booster shots now.
https://www.cnbc.com/2021/08/05/novavax-covid-vaccine-fda-emergency-use-submission-delayed-to-q4.html

Connie, many people are asking questions about immunity or antibodies from having had a COVID infection and if and when to get vaccinated. Mayo Clinic offers this guidance on its COVID vaccine page https://www.mayoclinic.org/coronavirus-covid-19/vaccine

"Should I get a COVID-19 vaccine if I’ve already had COVID-19?
Getting COVID-19 might offer some natural protection or immunity from reinfection with the COVID-19 virus. But it’s not clear how long this protection lasts.

Because it’s possible to get reinfected and COVID-19 can cause severe medical complications, the Centers for Disease Control and Prevention recommends that people who have already had COVID-19 get a COVID-19 vaccine.

If you were treated for COVID-19 with monoclonal antibodies or convalescent plasma, wait 90 days before getting a COVID-19 vaccine."
Read more details here: https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-vaccine/art-20484859#vaccine-benefits

Dr. Andrew Badley from Mayo Clinic talks about it in this video

Here is the latest CDC report on the need for vaccination even if you had Covid in the past: https://www.cdc.gov/mmwr/volumes/70/wr/mm7032e1.htm?s_cid=mm7032e1_w

Hi Everyone a little update on a couple of fronts, I just watched an update from Dr Poland during a q&a with the Arizona Doctors and at the 1 hr 4 min mark he mentioned that the Novavax Vaccine according to the numbers he is seeing is a great candidate. And advised to stay tuned for that one becoming available.

In the news I see manufacturer delays are causing the company to wait until 4th quarter for FDA filing for EUA use son hoping it becomes an option soon
Here is the link to the video.

Interesting. Thank you for sharing.

I just wanted to update my situation. It has been 9 months after coming down with Covid-19 and being given Bamlanivimab monoclonal antibody therapy. I was just retested this week and I still have antibodies. However, my husband who had Covid and received Bamlanivimab no longer has antibodies so he received the Johnson and Johnson vaccination. I am masking up (required where I live) but am hoping my antibodies will carry me over until Novovax becomes available.
To me it seems there is no follow up on who received monoclonal antibody therapy and their reaction to the different vaccinations. Also the fully vaccinated people who test positive for Covid months later after vaccination ... which vaccination was received? Other countries are publishing this data but in the US, it is silent here. Other people in the medical field has voiced this concern.

You can read about the CDC tracking of breakthrough infection tracking here: https://www.cdc.gov/vaccines/covid-19/health-departments/breakthrough-cases.html For some reason, back in May the CDC decided to track only those cases which resulted in hospitalization or death.

Many states are still doing comprehensive breakthrough tracking. Minnesota reports theirs weekly in their comprehensive Covid-19 report: https://www.health.state.mn.us/diseases/coronavirus/stats/vbt.html The latest report shows the total number of Covid positive cases reported in Minnesota after full vaccination (14 days after completed vaccine process. ) Here are the Minnesota numbers for February through August:
Total cases: (5,640,000 population)
190,000 positive tests (3300/100,000)
11,000 hospitalizations (195/100,000)
1,175 deaths (21/100,000)
Fully Vaccinated cases: (3,000,000 or 53% of population)
12,559 positive tests (220/100,000)
810 hospitalizations (14/100,000)
80 deaths (1.4/100,000)
That means about 7% of cases, hospitalizations and deaths are occurring in the vaccinated population (53% of the state) and 93% are in the unvaccinated people (47% of the state)
We could repeat this exercise state by state, but it reflects what the hospitals and health departments are reporting nationwide.

As to which vaccines experience the most breakthrough, the best information I could find was in VAERS, where about 12,600 have reported a positive Covid test after vaccination (but we don't know how long after or how many doses they had received.) This is a self-reporting system typically used to report vaccine reactions, so we don't know if people used it to report subsequent infections or not. It just gives some idea of the ratio of reported positives to total vaccine doses.
By vaccine:
Johnson & Johnson 889 cases (14 million doses)
Moderna 3,876 cases (66 million doses)
Pfizer 7,870 cases (95 million doses)

As to tracking vaccination information for people who have received monoclonal antibodies, I cannot see how that could be tracked. People receive these for hundreds of diseases and conditions in addition to Covid treatment. There is no requirement, upon receiving the Covid vaccine, to list every current and/or previous medication ever taken, which would be the only way gather this data. During vaccine testing, conditions and medications were tracked, so any known contraindications would have been noted.

Thank you Dana.

Thank you for the information. It was very informative. I would like to add, however, when my husband and I received the monoclonal antibody therapy, we offered to be available if the hospital needed follow up information. We were told it was not necessary, they weren't going to track the patients who received it.

Wow! That surprises me since all of these meds are being used for Covid either with EUA (Emergency Use Authorization) or off-label, I would have assumed all were being tracked.
Bamlanivimab was under an EUA. How will we ever know its safety or effectiveness if it is not tracked?